Find Academic Supervisors

Antonio Piñero MadronaView profile

Associate Professor

• Hematology
• Hematopoietic Transplantation
• Cell Therapy
• +7 more

Antonio Piñero Madrona is an Associate Professor in the Department of Surgery, Pediatrics, Obstetrics and Gynecology at the University of Murcia's Faculty of Medicine. His research focuses on hematology, hematopoietic transplantation, cell therapy, and breast cancer treatment. He leads the 'Hematology, Hematopoietic Transplantation and Cell Therapy' research group and has contributed to consensus documents on sentinel lymph node biopsy and intraoperative radiotherapy in breast cancer. Education: Earned his Doctorate from the University of Murcia in 1998 with a thesis on parathyroid gland imaging in primary hyperparathyroidism. His clinical training includes roles in surgical oncology and interventional radiology. Research Interests: Prioritizes translational studies in breast cancer management, transcatheter valve interventions, and novel imaging techniques. Key areas include optimizing sentinel lymph node detection, managing post-neoadjuvant therapy outcomes, and advancing minimally invasive surgical technologies. Publications: Over 40 peer-reviewed articles since 2003, focusing on TAVI outcomes, inflammatory bowel disease treatment, and breast cancer consensus guidelines. His work frequently integrates clinical and methodological innovations in surgical oncology. Awards: No specific awards listed, but his contributions to multidisciplinary clinical guidelines reflect peer recognition. Grants & Advising: No explicit grant details provided. Thesis supervised by Dr. José Manuel Rodríguez González. Active in collaborative research networks including the Spanish TAVI registry and SESP-M breast cancer working group. Labs/Teams: Collaborates with the Hematology and Clinical Radiology research groups, focusing on translational surgical oncology and novel diagnostic platforms.

Sara AlknerView profile

Associate Professor

• Breast Cancer
• Oncology
• Radiotherapy
• +3 more

Sara Alkner is an Associate Professor and Principal Investigator at Lund University Cancer Centre (LUCC), affiliated with Lund University's Faculty of Medicine. Her primary research focuses on breast cancer treatment, including radiotherapy optimization and clinical trials related to oncological interventions. She leads the T-REX trial, exploring tailored radiotherapy strategies for breast cancer patients. Her research interests encompass breast cancer prognosis, therapeutic procedures, and the application of medical technologies like surface-guided radiotherapy. She actively contributes to Sustainable Development Goals related to health and well-being through her work. Key achievements include three notable awards: the Bästa Vetenskapliga Ansökan (2022), recognition for her role in advancing surface-guided radiotherapy (2019), and the Guldpillret (2013). Her work is featured in high-impact journals like the New England Journal of Medicine and The Lancet Oncology. Dr. Alkner supervises research projects and has organized numerous academic events, including LUCC retreats and seminars. She collaborates internationally and is a key figure in multidisciplinary oncology research.

• Alternative Splicing
• Head & Neck Cancer
• Computational Biology
• +3 more

Theresa Guo is an Assistant Professor in the Department of Otolaryngology-Head & Neck Surgery at the University of California, San Diego (UCSD). With a background in mechanical engineering and medicine, her research focuses on post-transcriptional genomic alterations in head and neck cancers, particularly alternative splicing events that bridge DNA mutations and protein phenotypes. She employs computational biology approaches to advance precision cancer care. Education: BS in Mechanical Engineering, MIT MD, Cleveland Clinic Lerner College of Medicine Residency in Otolaryngology-Head & Neck Surgery, Johns Hopkins Hospital Fellowship in Head & Neck Surgical Oncology, MD Anderson Cancer Center Research Interests include alternative splicing in cancer, HPV-related oropharyngeal tumors, neoantigen discovery, and computational modeling of tumor heterogeneity. Her work addresses understudied gaps in genomic knowledge to improve therapeutic outcomes. Recent Publications highlight computational tools like OutSplice for splicing analysis, HPV oncogenic pathways, methylation-driven gene regulation, and clinical studies on treatment resistance and survival disparities. Key fields include head & neck oncology, molecular biology, and bioinformatics. Collaborations span multidisciplinary teams at UCSD and institutions like Johns Hopkins and MD Anderson, with co-authorships on studies involving immunotherapy, surgical outcomes, and epigenetic mechanisms.

Christopher S. HollenbeakView profile

Professor

• Health Economics
• Cost-Effectiveness Analysis
• Medical Decision Making
• +4 more

Christopher S. Hollenbeak is Professor and Chair of Health Policy and Administration, as well as Professor in the Department of Surgery and Public Health Sciences at The Pennsylvania State University. He holds a PhD in Economics from Washington University in St. Louis and has an extensive research portfolio focused on health economics, cost-effectiveness analysis, and clinical outcomes research. Education B.A., Economics, Brigham University M.A., Economics, Washington University in St. Louis Ph.D., Economics, Washington University in St. Louis His research interests span cost-effectiveness of medical interventions, health policy analysis, surgical outcomes, and heart failure management. Key projects include evaluating the financial impact of cancer treatments, analyzing end-of-life care in complex organizations, and studying resource utilization in chronic disease management. Recent publications focus on predictive modeling in endocrinology, cardiovascular surgery trends, and sleep-related outcomes in heart failure patients. His work frequently addresses health disparities, quality of care metrics, and economic implications of clinical decisions.

Fredrik StrandView profile

Researcher

• Artificial Intelligence
• Medical Imaging
• Breast Cancer Research
• +3 more

Fredrik Strand is a researcher at the Karolinska Institute , specifically within the Department of Oncology-Pathology under the Faculty of Medicine . He leads the Computational Breast Imaging Group , focusing on leveraging Artificial Intelligence (AI) for early breast cancer detection , precision diagnostics , and image-guided minimally invasive procedures . His work spans cross-disciplinary collaboration with institutions like the Royal Institute of Technology (KTH) and involves major clinical trials such as ScreenTrustCAD and ScreenTrustMRI . His research emphasizes AI in precision screening to address interval cancers and optimize radiologist workflows. Projects like VAI-B and RadioVal aim to validate AI algorithms and predict therapy response for neoadjuvant treatment . Recent publications highlight advancements in multi-modality imaging (mammography, MRI), GAN-based synthetic data generation , and trustworthy AI frameworks for clinical deployment. A consistent focus is on cost-effectiveness , equity in AI diagnostics , and human-AI interaction dynamics . Key trends in his work include deep learning for tumor detection , reinforcement learning for screening policies , and multi-institutional validation of AI tools. His research is funded by organizations such as Medtechlabs , Vinnova , EU Horizon Europe , and the Swedish Breast Cancer Association .

Jörg TraubView profile

Lecturer

• Navigation and Computer Aided Surgery
• Evaluation of Navigation Systems in Medicine
• Augmented Reality in Medicine
• +4 more

Dr. Jörg Traub is a Senior Researcher and Lecturer at the Chair for Computer Aided Medical Procedures & Augmented Reality at Technische Universität München (TUM). He holds academic roles as a Lecturer in courses such as 'Innovation Generation in the Healthcare Domain' and 'Medical Augmented Reality', and serves as a Senior Affiliate Lecturer/Research Scientist. His research focuses on navigation systems, augmented reality in medicine, and hybrid surgical interfaces. Currently, he is also a Project Manager at Bayern Innovativ GmbH and Managing Director of Forum Medtech Pharma eV. Dr. Traub's work bridges academic research and industry innovation. He has supervised numerous theses on topics like electromagnetic tracking error correction, navigated bronchoscopy, and surgical navigation systems. His 2005 diploma thesis on augmented reality navigation tools earned him the Werner von Siemens Excellence Award. He has contributed to projects such as heARt (enhanced cardiac surgery via AR), PORT (robotic cardiovascular surgery navigation), and STENT (endoscopic stent implantation). His teaching spans over a decade, with courses in computer-aided medical procedures, surgical robotics, and medical imaging. He actively organizes academic events, including workshops at MICCAI and ISMAR conferences. His research outputs include pioneering work on freehand SPECT, mobile C-arm systems, and fusion imaging techniques for clinical applications. Dr. Traub collaborates with institutions like the German Heart Center Munich (DHM) and leads teams in labs such as the NARVIS Lab. His contributions span from fundamental research to clinical translation, emphasizing workflow-driven evaluation and user-centric design in surgical technologies.

Stephanie ChamView profile

Assistant Professor

• Gynecologic Oncology
• Health Services Research
• Patient-Centered Care
• +4 more

Dr. Stephanie Cham is an Assistant Professor at the University of California San Francisco (UCSF) in the Department of Obstetrics and Gynecology. As an NIH Women’s Reproductive Health Research scholar, her work focuses on reducing disparities in gynecologic cancer care, particularly for frail and elderly patients, through healthcare services research and technology-driven interventions. Education: MD from UCLA David Geffen School of Medicine (2015), Residency at Columbia University (2019), Fellowship at Brigham and Women's Hospital/Dana-Farber Cancer Institute (2022) Her research spans perioperative care optimization, frailty assessment in gynecologic oncology, and addressing insurance inequities in cancer treatment. Recent work examines fragmented care, risk prediction tools, and prehabilitation strategies for aging populations. Publications appear in high-impact journals like JAMA Oncology and Gynecologic Oncology. She has received multiple awards for teaching, mentoring, and research, including the Society of Gynecologic Oncology BRIDGES Scholar (2024) and ASCO Young Investigator Award (2022). Her clinical focus includes surgical excellence and training future physicians.

Rafi SheikhView profile

Associate Professor

• Ophthalmology
• Photoacoustic Imaging
• Laser Speckle Contrast Imaging
• +5 more

Rafi Sheikh serves as Associate Professor and Senior Consultant at Lund University's Department of Ophthalmology, with affiliations to the Ophthalmology Imaging Research Group, LTH Photon Science and Technology Profile Area, and LU Light and Materials Profile Area. His research bridges clinical ophthalmology with advanced imaging technologies. Specializing in non-invasive imaging techniques , Sheikh's work focuses on photoacoustic imaging for oxygenation measurements, laser speckle contrast imaging for perfusion mapping, and thermographic analysis in oculoplastic procedures. His fingerprint reveals significant contributions to Perfusion (100%), Photoacoustic Imaging (57%), Blood analysis (51%), and Eyelid Surgery (49%) research domains. Recent publications demonstrate consistent innovation in ophthalmic diagnostics , particularly for uveal melanoma vascular mapping, diabetic retinopathy biomarkers, and prosthetic eye complications. His work integrates engineering solutions with clinical ophthalmology to address unmet diagnostic needs. Sheikh actively supervises doctoral candidates including Hector, S. on hyperspectral imaging for diabetic complications, and participates in six major research projects spanning breast cancer diagnostics, giant cell arteritis detection, and flap monitoring during reconstructive surgery. His laboratory work centers on the Ophthalmology Imaging Research Group where novel optical techniques are translated to clinical applications.

• Medicine
• Surgery
• General Surgery
• +5 more

Assoc. Prof. Onur Dülgeroğlu is an Associate Professor at Acibadem Mehmet Ali Aydinlar University’s School of Medicine, Department of Surgical Sciences. He specializes in breast cancer surgery, surgical oncology, and postoperative complications, with a focus on advanced imaging techniques like PET/CT and MRI for axillary staging. Education: Expertise in Medicine (2014) and Undergraduate (2004) from Izmir Katip Celebi University and Ondokuz Mayis University, respectively. Research Interests: Medicine, Surgery, General Surgery, and Health Sciences, particularly in breast cancer treatment, surgical innovation, and pandemic-related surgical outcomes. His recent work includes clinical trials on axillary management in breast cancer patients (SENATURK-OTHELLO Study, SENATURK OTHER-NAC Study) and studies on surgical preparedness during global health crises. He has published extensively in SCI/SSCI-indexed journals like Clinical Breast Cancer , European Journal of Surgical Oncology , and The Lancet series, with over 96 publications and 756 Scopus citations. Prof. Dülgeroğlu has served as a peer reviewer for journals such as JAMA and PLOS ONE , and participates in scientific congresses including Breastanbul, Istanbul International Breast Cancer Conference, and European Society of Endocrine Surgeons events. His work bridges clinical practice, surgical innovation, and global health policy.

Nirupama AnneView profile

Associate Professor

• Breast Cancer
• Surgical Oncology
• Inflammatory Breast Cancer
• +4 more

Nirupama Anne, MD is an Associate Professor in the Department of Surgery at Penn State College of Medicine. She is a fellowship-trained, board-certified breast surgeon specializing in surgical oncology with expertise in breast cancer management, image-guided biopsies, and complex general surgical oncology procedures. Her clinical focus encompasses Breast Cancer , Inflammatory Breast Cancer , Breast Lymphoma , and Sentinel Lymph Node Biopsy techniques. She previously served as Medical Director of the Breast Surgery Program at Prisma Health in Columbia, South Carolina, and contributes to national guideline development through the American Society of Clinical Oncology Expert Panel. Analysis of her research output (2005-2011) reveals concentrated expertise in breast oncology and rare metastatic patterns, with significant contributions to understanding pneumatosis intestinalis in transplant patients and diagnostic challenges in breast lymphoma mimicking inflammatory breast cancer. Her work demonstrates strong clinical-translational focus with multiple high-impact publications in surgical oncology journals. Gold Medalist in Academic Achievement, New York University Summa Cum Laude, New York University Syracuse Health Science Center Medical Alumni Foundation Scholarship Award Teaching Scholars Award, National Science Foundation ASCO Guideline Expert Panel for Sentinel Lymph Node Biopsy (2023-present) Society of Surgical Oncology Fellowship Training Committee (2024-present) Dr. Anne actively mentors through the American College of Surgeons Women in Surgery Committee mentorship subcommittee and serves as a key contributor to national surgical oncology training standards. Her clinical practice spans the Penn State Health Breast Center in Hershey and the Century Drive Cancer Center in Mechanicsburg, where she provides comprehensive breast disease management including ultrasound and stereotactic guided procedures.

Taner KıvılcımView profile

Part-Time Lecturer

• Breast Surgery
• Endocrine Surgery
• Oncologic Surgery
• +5 more

Dr. Taner Kıvılcım is a part-time lecturer in the Department of General Surgery at Istanbul Okan University, with expertise in Breast Surgery, Endocrine Surgery, and Oncologic Surgery. He has been affiliated with Okan University Hospital since 2016 and previously worked at state hospitals in Turkey. Educational Background: Medical Degree: Eskişehir Osmangazi University Faculty of Medicine (2008) Specialization: Sakarya University Training and Research Hospital (2014) Research Interests focus on breast pathologies (e.g., granulomatous mastitis, phyllodes tumors), endocrine surgery (thyroid/parathyroid), gastrointestinal stromal tumors, and surgical complications (e.g., anastomotic healing, pilonidal sinus). His work also includes studies on kidney transplantation and infection prevention in surgical settings. Scientific Contributions include over 20 peer-reviewed publications and book chapters. Recent articles (2022-2025) explore topics such as: Postoperative infection control in transplantation Novel surgical techniques for pilonidal sinus Oncologic safety of axillary procedures in breast cancer Biomarkers for acute abdomen diagnosis Epidemiologic studies on breast cancer delays Professional Engagement includes participation in national and international surgical congresses, editorial roles, and certifications in laparoscopic surgery, emergency surgery, and breast imaging. He is a member of the Turkish Surgical Association and the National Breast Surgery Association.

Anthony B. CostalesView profile

Assistant Professor

• Gynecologic Oncology
• Hyperthermic intraperitoneal chemotherapy (HIPEC)
• Minimally invasive surgery
• +9 more

Anthony B. Costales, M.D. serves as an Assistant Professor in the Department of Gynecologic Oncology at Baylor College of Medicine's Dan L Duncan Comprehensive Cancer Center in Houston, Texas. His clinical practice focuses on providing comprehensive medical and surgical care for women with gynecologic cancers, with expertise in minimally invasive robotic and laparoscopic procedures for uterine and early-stage ovarian cancers. Dr. Costales completed his BS in Cell and Molecular Biology and Chemistry from Missouri State University (2008), followed by his MD from The University of Texas at Houston McGovern Medical School (2012). He completed his Obstetrics and Gynecology residency at UTHealth (2016) and a Gynecologic Oncology fellowship at the Cleveland Clinic Foundation (2019). His research interests center on surgical clinical trials to optimize gynecologic cancer outcomes, with particular emphasis on hyperthermic intraperitoneal chemotherapy (HIPEC) for advanced ovarian cancers and minimally invasive surgical techniques. Analysis of Dr. Costales' publication record reveals a strong concentration on HIPEC applications and minimally invasive surgical approaches for gynecologic malignancies. His work spans ovarian cancer treatment optimization, cervical cancer management innovations, and surgical technique refinement, with recent studies focusing on comparative effectiveness between minimally invasive and open surgical approaches for advanced disease. Dr. Costales has received professional recognition including: 2020 Texas Super Doctors Rising Stars 2021 Texas Super Doctors Rising Stars He actively contributes to significant research initiatives including the MIID-SOC trial investigating minimally invasive interval debulking surgery in ovarian cancer and the MAN-U Trial examining uterine manipulation during minimally invasive surgery for early stage endometrial cancer. His participation in the Robotic Training Network Curriculum demonstrates commitment to advancing surgical techniques through professional development. As part of the Dan L Duncan Comprehensive Cancer Center, Dr. Costales collaborates within a multidisciplinary team approach to cancer care, integrating cutting-edge research with clinical practice to advance treatment options for women with gynecologic cancers.

• Oncology
• Nuclear Medicine
• Pain Management
• +3 more

Fritsch A. is an active researcher publishing across multiple medical disciplines including oncology, pain management, plastic surgery, and AI applications in medicine. The publication record from 2025 indicates ongoing research activity across various clinical domains. Research interests span several key areas: clinical oncology with focus on ovarian cancer detection techniques; pain management research particularly regarding diabetic neuropathy; plastic and reconstructive surgery with emphasis on microsurgical techniques and resident training; and emerging applications of artificial intelligence in patient care after surgical procedures. The work demonstrates a strong clinical research focus with translational applications. The publication portfolio shows a trend toward interdisciplinary research, particularly at the intersection of traditional medical specialties and emerging technologies. Several publications address methodological improvements in clinical practice, including novel imaging techniques, drug monitoring approaches, and evaluation of new therapeutic interventions. The research often involves multi-institutional collaborations as indicated by the author lists. Active participation in clinical trials research, particularly in pain management Contributions to surgical education methodology Exploration of AI applications in postoperative patient care Methodological improvements in drug concentration monitoring

• Breast Cancer
• Axillary Surgery
• Sentinel Node Procedure
• +2 more

Tove Holst Filtenborg Tvedskov holds a dual appointment as Clinical Professor at the University of Copenhagen's Faculty of Health and Medical Sciences and consultant in breast surgery at the Department of Breast Surgery, Gentofte Hospital, Capital Region of Denmark. She maintains an active clinical and research career focused on breast cancer surgery with particular emphasis on optimizing axillary procedures. Her educational background includes an MD from the University of Aarhus (1995), PhD from the University of Copenhagen (2012) on omitting axillary clearance in sentinel node micrometastases, and DMSc (dr.med.) in 2017 on the evolution of sentinel node procedures. She became a specialist in surgery in 2007 and subspecialized in breast surgery in 2013. Professor Tvedskov's research primarily focuses on de-escalating axillary surgery in breast cancer treatment. Her work centers on determining which patients can safely avoid extensive axillary lymph node dissection while maintaining optimal oncological outcomes. This research has significant implications for reducing postoperative morbidity while preserving cancer control. Analysis of her recent publications reveals a strong focus on clinical trials evaluating axillary management strategies, particularly the SENOMAC trial which examines omitting axillary dissection in sentinel node positive patients. Her work spans surgical techniques, imaging modalities for staging, and reconstruction methods, demonstrating a comprehensive approach to breast cancer care that integrates surgical oncology with plastic surgery considerations. Professor Tvedskov serves in multiple leadership roles including member of the SENOMAC trial steering committee, principal investigator for the DBCG RT RECON trial on delayed-immediate breast reconstruction, head of the national steering committee for the MELODY trial, member of the Danish Breast Cancer Group (DBCG) steering board, head of the DBCG surgical board, and member of the Nordic Breast Cancer Network (NBCN) steering group. Her research has been supported by numerous funding sources including Pink Tribute, Kræftens Bekæmpelse, ACROBATIC, Region Hovedstaden, Herlev-Gentofte Hospital, Danish Comprehensive Cancer Center, Landsforeningen mod Brystkræft, and several foundation grants. She has received travel grants from Harboefonden, Lundbeckfonden, Kræftens Bekæmpelse, Novartis Oncology, Rigshospitalet, and MSD. Professor Tvedskov is actively involved in the national and international breast cancer research community, collaborating with multiple institutions across Europe. Her work has been recognized through extensive citations, media coverage, and incorporation into clinical guidelines, demonstrating significant impact on breast cancer treatment protocols.

Kristine WiddersView profile

Assistant Professor

• Breast Cancer
• Surgical Oncology
• Tumor Recurrence
• +3 more

Kristine Widders, MD serves as an Assistant Professor in the Department of Surgery within the College of Medicine at Pennsylvania State University, specializing in General Surgery and Surgical Oncology at the Penn State Cancer Institute. Her research focuses on critical aspects of breast cancer survivorship and diagnostics, including: Mechanisms of ipsilateral breast tumor recurrence and surgical management Sociodemographic disparities affecting rehabilitation outcomes Advanced imaging techniques for rare breast tumors like granular cell neoplasms Arm function restoration protocols post-mastectomy Analysis of her publications reveals a concentrated trajectory in breast oncology since 2016, with increasing emphasis on multidisciplinary approaches integrating surgical oncology, radiology, and rehabilitation science. Her 2024 work demonstrates innovative cross-application of prostate cancer imaging technology to breast diagnostics. Dr. Widders actively collaborates with national research teams across institutions, with her 2022 review on work reintegration disparities accumulating significant scholarly attention (40 Mendeley readers). Her laboratory and clinical teams focus on: Longitudinal tracking of breast cancer survivorship metrics Optimizing sentinel lymph node biopsy success rates Developing disparity-sensitive rehabilitation frameworks